<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ppharm-362</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПО МАТЕРИАЛАМ EPA/UNEPSA И IPA</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Materials (WHO, EPA/UNESPA, IPA)</subject></subj-group></article-categories><title-group><article-title>ГАЗЕТА ЕВРОПЕЙСКОЙ ПЕДИАТРИЧЕСКОЙ АССОЦИАЦИИ, 12-Й ВЫПУСК</article-title><trans-title-group xml:lang="en"><trans-title>EPA NEWSLETTER/ISSUE 12/DECEMBER 2011</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editor</surname><given-names>Article</given-names></name></name-alternatives><email xlink:type="simple">neonatepearl@yandex.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>04</day><month>04</month><year>2012</year></pub-date><volume>9</volume><issue>2</issue><issue-title>Педиатрическая фармакология</issue-title><fpage>146</fpage><lpage>155</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editor A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/362">https://www.pedpharma.ru/jour/article/view/362</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">American Academy of Pediatrics. Subcommittee on management of acute otitis media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113:141-65.</mixed-citation><mixed-citation xml:lang="en">American Academy of Pediatrics. Subcommittee on management of acute otitis media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113:141-65.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Azarpazhooh A., Limeback H., Lawrence H.P., Prakesh- kumar S.S. Xylitol for preventing acute otitis media in children up to 12 years of age. Cochrane Database Syst Rev. 2011 Nov 9;11: CD007095.</mixed-citation><mixed-citation xml:lang="en">Azarpazhooh A., Limeback H., Lawrence H.P., Prakesh- kumar S.S. Xylitol for preventing acute otitis media in children up to 12 years of age. Cochrane Database Syst Rev. 2011 Nov 9;11: CD007095.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and Prevention (CDC). Office-related antibiotic prescribing for persons aged ^ 14 years — United States 1993-94 to 2007-08. MMWR Morb Mortal Wkly Rep 2011; 60:1153-6.</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and Prevention (CDC). Office-related antibiotic prescribing for persons aged ^ 14 years — United States 1993-94 to 2007-08. MMWR Morb Mortal Wkly Rep 2011; 60:1153-6.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen R., Levy C., Bonnet E., Thollot F., Boucherat M., Fritzell B. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis 2011;11: 95-6.</mixed-citation><mixed-citation xml:lang="en">Cohen R., Levy C., Bonnet E., Thollot F., Boucherat M., Fritzell B. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis 2011;11: 95-6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines and Protocols Advisory Committee -Otitis media: Acute otitis media. 2010. http://www. bcguidelines.ca/guideline_otits.html</mixed-citation><mixed-citation xml:lang="en">Guidelines and Protocols Advisory Committee -Otitis media: Acute otitis media. 2010. http://www. bcguidelines.ca/guideline_otits.html</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hoberman A. Paradise J.L., Shaikh N., Greenberg D.P., Kearney D.H., Colborn D.K. Pneumococcal resistance and serotype 19A in Pittsburg-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phil) 2011; 50; 114-20.</mixed-citation><mixed-citation xml:lang="en">Hoberman A. Paradise J.L., Shaikh N., Greenberg D.P., Kearney D.H., Colborn D.K. Pneumococcal resistance and serotype 19A in Pittsburg-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phil) 2011; 50; 114-20.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Underwood M., Bakaletz L. innate immunity and the role of defensins in otitis media. Curr Allergy Asthma Rep. 2011; 11: 499-507.</mixed-citation><mixed-citation xml:lang="en">Underwood M., Bakaletz L. innate immunity and the role of defensins in otitis media. Curr Allergy Asthma Rep. 2011; 11: 499-507.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Veenhoven R., Bogaert D., Uitervaal C., Brower C., Kiezebrink N. Effect of conjugate pneumococcal vaccine followed by polisaccharidepneumococcal vaccine on recurrent acute media: a randomized study. Lancet 2003; 361: 2189-95.</mixed-citation><mixed-citation xml:lang="en">Veenhoven R., Bogaert D., Uitervaal C., Brower C., Kiezebrink N. Effect of conjugate pneumococcal vaccine followed by polisaccharidepneumococcal vaccine on recurrent acute media: a randomized study. Lancet 2003; 361: 2189-95.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wiertsema S.P., Chidlow G.R., Kirkham L.A., Corscad- den K.J., Mowe E.N., Vijayasekaran S. High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol 2011; 83: 2008-17.</mixed-citation><mixed-citation xml:lang="en">Wiertsema S.P., Chidlow G.R., Kirkham L.A., Corscad- den K.J., Mowe E.N., Vijayasekaran S. High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol 2011; 83: 2008-17.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
